Home PRNewsWire

    PRNewsWire

    0
    348
    RSS Source: https://www.prnewswire.com/
    Default Action: directlink
    Default Link Follow: nofollow
    Default Link Target: newtab
    Affiliate Code:
    Default Link Color is defined : #FF6C36
    Feed Title: All News Releases

    AstraZeneca (AZN) announced its key CARDIO-TTRansform Phase III trial missed its primary endpoint. SueWallSt notifies investors of a pending investigation into potential securities claims on behalf of affected AZN investors. NEW YORK, July 9, 2026 /PRNewswire/ -- AstraZeneca PLC (NYSE:...

    Ionis Pharmaceuticals told investors its CARDIO-TTRansform program was on track to deliver landmark data -- then the Phase-3 trial missed its primary endpoint. Levi & Korsinsky is investigating. NEW YORK, July 9, 2026 /PRNewswire/ -- Ionis Pharmaceuticals (NASDAQ: IONS) shares were...

    Da visuelle Standards anspruchsvoller und Produktkataloge immer komplexer werden, stehen Marken und Einzelhรคndler vor derselben Herausforderung: Es gibt keine zuverlรคssige Mรถglichkeit, die Einhaltung visueller Vorgaben zu รผberwachen, Verbesserungen zu priorisieren und sicherzustellen,...

    New permanent community space will provide year-round access to soccer, mentorship, and life-skills programming for families in fire-affected neighborhoods ALTADENA, Calif., July 9, 2026 /PRNewswire/ -- UNIQLO and Street Soccer USA today announced the opening of the UNIQLO Street Soccer...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Jefferies Financial Group Inc. ("Jefferies" or the "Company") (NYSE: JEF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Megan Holdings Limited ("Megan" or the "Company") (NASDAQ: MGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alarum Technologies Ltd. ("Alarum" or the "Company") (NASDAQ: ALAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Franklin Covey Co. ("Franklin Covey" or the "Company") (NYSE: FC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Futu Holdings Ltd. ("Futu" or the "Company") (NASDAQ: FUTU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Black Rock Coffee Bar, Inc. ("Black Rock" or the "Company") (NASDAQ: BRCB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hyliion Holdings Corp. ("Hyliion" or the "Company") (NYSE: HYLN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Wheels Up Experience Inc. ("Wheels Up" or the "Company") (NYSE: UP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Photronics, Inc. ("Photronics" or the "Company") (NASDAQ: PLAB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Elastic N.V. ("Elastic" or the "Company") (NYSE: ESTC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alibaba Group Holding Limited ("Alibaba" or the "Company") (NYSE: BABA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Solstice Advanced Materials, Inc. ("Solstice" or the "Company") (NASDAQ: SOLS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Copart, Inc. ("Copart" or the "Company") (NASDAQ: CPRT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Ensign Group, Inc. ("Ensign Group" or the "Company") (NASDAQ: ENSG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

    NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Omeros Corporation ("Omeros" or the "Company") (NASDAQ: OMER). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...

    Advertisment
    Previous articleBocafirst
    Next articleScienceMag Headlines

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Chat with us!
      X
      Welcome to 4boca. I'm BocaBot.